Literature DB >> 24263073

The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.

Eloisa Arbustini1, Navneet Narula, G William Dec, K Srinath Reddy, Barry Greenberg, Sudhir Kushwaha, Thomas Marwick, Sean Pinney, Riccardo Bellazzi, Valentina Favalli, Christopher Kramer, Robert Roberts, William A Zoghbi, Robert Bonow, Luigi Tavazzi, Valentin Fuster, Jagat Narula.   

Abstract

Entities:  

Keywords:  cardiomyopathy; diastolic dysfunction; heart failure; heart muscle disease; myocardial hypertrophy; systolic dysfunction; ventricular arrhythmias

Mesh:

Year:  2013        PMID: 24263073     DOI: 10.1016/j.jacc.2013.08.1644

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  40 in total

Review 1.  Role of non-invasive imaging in the work-up of cardiomyopathies.

Authors:  Lakshmi S Tummala; Raymond K Young; Tania Singh; Sandeep Jani; Monvadi B Srichai
Journal:  Curr Atheroscler Rep       Date:  2015-03       Impact factor: 5.113

2.  MOGE(S) nosology in low-to-middle-income countries.

Authors:  Eloisa Arbustini; Navneet Narula; G William Dec; K Srinath Reddy; Barry Greenberg; Sudhir Kushwaha; Thomas Marwick; Sean Pinney; Riccardo Bellazzi; Valentina Favalli; Christopher Kramer; Robert Roberts; William A Zoghbi; Robert Bonow; Luigi Tavazzi; Valentin Fuster; Jagat Narula
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

3.  Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies?

Authors:  Bongani M Mayosi
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 4.  Re-evaluating the causes and consequences of non-resolving inflammation in chronic cardiovascular disease.

Authors:  Amanda B Pullen; Jeevan Kumar Jadapalli; Boutayna Rhourri-Frih; Ganesh V Halade
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 5.  Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.

Authors:  Han-Chih Hencher Lee; Chor-Kwan Ching
Journal:  Clin Biochem Rev       Date:  2019-11

6.  Response to cardiac resynchronization therapy in non-ischemic cardiomyopathy is unrelated to medical therapy.

Authors:  Gregory Sinner; Hesham R Omar; You W Lin; Samy C Elayi; Maya E Guglin
Journal:  Clin Cardiol       Date:  2018-12-15       Impact factor: 2.882

Review 7.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

Review 8.  Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis.

Authors:  Francesco Negri; Antonio De Luca; Enrico Fabris; Renata Korcova; Carlo Cernetti; Chrysanthos Grigoratos; Giovanni Donato Aquaro; Gaetano Nucifora; Paolo G Camici; Gianfranco Sinagra
Journal:  Heart Fail Rev       Date:  2019-05       Impact factor: 4.214

Review 9.  The MOGE(S) classification for cardiomyopathies: current status and future outlook.

Authors:  Julian G Westphal; Angelos G Rigopoulos; Constantinos Bakogiannis; Sarah E Ludwig; Sophie Mavrogeni; Boris Bigalke; Torsten Doenst; Matthias Pauschinger; Carsten Tschöpe; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 10.  Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.

Authors:  Brendan N Putko; Kevin Wen; Richard B Thompson; John Mullen; Miriam Shanks; Haran Yogasundaram; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.